This analysis carried out on a large number of medulloblastomas showed frequent MYC amplifications in Group 3 and WNT medulloblastomas; in contrast, MYCN amplifications were frequent in SHH and Group 4 tumors [172]. The gene discussed is MYCN; the disease is medulloblastoma.